Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus applies to the DCGI for EUA to launch ZyCoV-D, the world's first Plasmid DNA vaccine for COVID-1901-07-2021
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus applies to the DCGI for EUA to launch ZyCoV-D, the world's first Plasmid DNA vaccine for COVID-19COVID-19: Zydus Cadila vaccine likely to be available for 12-18 years age group by Aug
The Ahmedabad-based company's ZyCoV-D is a DNA plasmid vaccine, which uses a portion of the genetic code -- DNA or RNA -- in the virus to stimulate an immune response.Zydus Cadila gets USFDA approval for generic cancer drug
The Ahmedabad-based drug maker has received approval from the US Food and Drug Administration (USFDA) for the injection in the strengths of 100mg/vial, 500 mg/vial, and 1000 mg/vial, single-dose vials, Zydus Cadila said in a statement.CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives tentative approval from USFDA for Pemetrexed for InjectionZydus Cadila gets tentative USFDA nod to market generic sclerosis treatment drug
The company has received tentative approval from the US Food and Drug Administration (USFDA) to market the product in the strength of .25 mg, Zydus Cadila said in a statementCadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mgCadila Healthcare Ltd - 532321 - Closure of Trading Window
Intimation of Trading Window ClosureCadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus and Bayer announce continuity of their successful Joint VentureCADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Updates on Joint Venture
Extention of the tenure of the joint venture agreement ('JVA') with Bayer (South East Asia) PTE Limited, one of the companies of the Bayer Group, for a period of three years.Zydus Cadila likely to seek EUA for its ZyCoV-D vaccine in 7-8 days
It will be the second indigenous Covid-19 vaccine to apply for such authorisation. It will also be the world's first DNA vaccine against coronavirus